Another strategist chops his S&P 500 target — but for a different reason than the Goldman Sachs reduction
The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...
An S&P correction exceeding 10% will inflict pain on global stocks, Goldman says
Global equities are likely to be yanked into the red should the S&P 500 (SP500) undergo a correction deeper than 10%, ...
Goldman's Oppenheimer warns U.S. stock market may continue to underperform
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Pensions & Investments1h
UPS investment staff moved to Goldman Sachs Asset Management. Here's how it went.
Ernie Caballero didn’t know how good working for a giant money manager could be. In September, the 35 year UPS veteran and ...
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized underwritten public offering of 2,808,988 shares of its common stock at a public ...
Rep. Marjorie Taylor Greene Purchases Shares of The Goldman Sachs Group, Inc. (NYSE:GS)
Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...